Money Daily

SBI Issues Key Update On Fundraising Up To $3 Bn, Shares Fall

SBI Issues Key Update On Fundraising Up To $3 Bn, Shares Fall

Public sector lender State Bank of India share price today settled with the decline of 1.20% to Rs 785.35 per share on Bombay Stock Exchange (BSE) as Sensex dived 872.98 points to 81,186.44. The PSU bank today issued key update on long term fundraising plan of approximately $3 billion. The Executive Committee of the Central Board of SBI today gave nod to the long-term fundraising plan of nearly $3 billion for the FY 2024-25, according to the BSE filing. Earlier on May 3, 2025, the PSU reported its financial results for Q4FY25. It reported a decline of 10% year-on-year (YoY) for Q4FY25 to Rs 18,642.59 crore as against the net profit of Rs 20,698.35 crore declared in the corresponding quarter of last year. The PSB also recommended a dividend of Rs 15.90 per share of the face value of Re 1/- each.

Meanwhile, it has a market capitalisation stood at Rs 7,00,895.03 crore with free float market cap at Rs 3,01,023.90 crore. The return on equity (ROE) of the bank stock is 17.39%. Life Insurance Corporation Of India (LIC) has 9.38% stake in SBI with 829,292,748 shares for the March 2025 quarter. Check more details below:

SBI Issues Key Update On Fundraising Up To $3 Bn, Shares Fall

SBI Approves Fundraising Plan

According to the exchange filing of the bank dated May 20, 2025, β€œThe Executive Committee of the Central Board of the Bank, pursuant to Regulation 30 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit that the Executive Committee of the Central Board in its meeting held on 20th May 2025 has approved, inter alia, to examine the status and decide on long term fund raising in single / multiple tranches of up to US$ 3 Billion (US$ Three Billion) under Reg-S/144A, through a public offer and/or private placement of senior unsecured notes in US Dollar or any other major foreign currency during FY 2025-26.”

SBI Shares Performance

The 52-week high of State Bank of India share price stood at Rs 912.10 per share (as on 03/06/2024) and 52-week low price is Rs 679.65 per share (as on 03/03/2025), respectively. State Bank of India share price slipped over 2% in last 1-week, gained 7.63% in last 3-months, and slipped 4.32% in last 1-year. The stock delivered returns of 36.57% in last 2-years, surged 69.81% in last 2-years, and offered impressive returns of 411.8% in last 5-years.

SBI Dividend 2025

According to the BSE filing issued as on May 3, 2025, β€œPursuant to Regulation 43 and Regulation 30 (6) of SEBI (LODR) Regulations, 2015, the Central Board of the Bank, has declared a Dividend of Rs15.90 per equity share (1590%) for the financial year ended 31.03.2025.” The record date for determining the eligibility of members entitled to receive dividend on equity shares is Friday, 16.05.2025 and dividend payment date is fixed as 30.05.2025.”

SBI Results Q4FY25

The bank’s net interest income or NII zoomed 2.7% year-on-year (YoY) to Rs 42,774.55 crore for Q4FY25 as against Rs 41,655 crore announced in Q4FY24. Net Interest Margin or NIM for domestic book declined 32 basis points YoY to 3.15% for Q4FY25 as compared to 3.47% declared in Q4FY24. The PSB reported interest expenses for Q4FY25 at Rs 76,892 crore as against Rs 69,387 crore reported in Q4FY24. SBI said its net interest margin (NIM) outlook remains connected to the interest rate cycle, and it anticipates further monetary easing in the coming quarters. The PSU reportedly revised its credit growth guidance for FY26 to 12–13%, down from the previous projection of 14–16%.

Disclaimer: The story highlights fundraising plan and should not be considered as investment advice by the Moneydaily.in or the Author.Β  Moneydaily.in and the author will not be held responsible for any losses caused as a result of decisions based on the above information. Moneydaily.in advises readers to do their own research or consult a SEBI registered investment advisor before making any investment decisions.

Recommended: Zydus Lifesciences Declares Marginal Dip In Net Profit, Highest Dividend Since 2015

 

Leave a Reply

Your email address will not be published. Required fields are marked *